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Foreword
Dear Colleagues
Welcome to the 8th Conference of the Serbian Biochemical Society, entitled 
"Coordination in Biochemistry and Life".
The title of this year’s Conference refers to an important place of coordination
chemistry in biochemistry and biomedicine, but also to a need to coordinate the efforts 
towards new knowledge with fellow scientists from other fields in order to reach more. 
The collaboration within FEBS3+ (Croatia, Hungary, Slovenia, and Serbia) Meeting 
Programme continues with the invited lecture of our dear colleague Tantos Ágnes from 
Research Center for Natural Sciences, Budapest, Hungary. For the first time we have 
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biochemistry who is now affiliated at the Université de Bordeaux. We have more than 
forty PhD students from Serbia, Hungary, and Belarus with poster presentations, and for 
the first time the Conference is held outside the capital. It believe that we are getting better 
each year, and that we are prepared for future challenges.
I would like to express my gratitude to the members of the Scientific Board who 
suggested lecturers, to all respected colleagues who accepted the invitation, and to our dear 
hosts from the University of Novi Sad.
Editor of the Proceedings
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Distribution and role of metals in sclerotic hippocampi 
of patients with mesial temporal lobe epilepsy
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The accumulating evidence on the relation between the disturbed metal homeostasis 
and epilepsy urges the need for data regarding the total metal concentrations, as well 
as metal distribution in the brain itself, in order to indicate where to direct the 
potential therapy, to metal supplementation or chelation. This paper summarizes our 
results on the measurements of some important essential metals in hippocampi of 
patients with mesial temporal lobe epilepsy (mTLE) who underwent 
amigdalohippocampectomy. The key findings point out that levels of copper and 
manganese are deficient in hippocampi of mTLE patients, and that their 
concentrations correlated positively with neuronal loss in affected regions of sclerotic 
hippocampus. In addition, the Cu concentration was decreased in the areas of total 
neuronal loss. Iron and zinc total hippocampal levels were neither accumulated nor 
deficient compared to control. Our results contribute to deeper insight of metals 
biology in the epilepsy and may represent the initial point of new and non-invasive 
therapy of drug resistant epilepsy.
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Introduction 
Epilepsy is neurological condition which is clinically manifested as spontaneous, recurrent 
epileptic seizures, due to short-term, uncontrolled and highly synchronized outburst of 
electrical activity of larger group of neurons in the brain. As a result, balance between 
brain excitability and inhibition is disturbed and shifted in favor of excitatory state. 
Epilepsy is accounted for one of the most common among serious neurological disorders. 
It affects about 50 million people worldwide, with 50 new cases per 100,000 per annum 1.
It is estimated that 1% of each population suffers from epilepsy at any time point. Despite 
that, many uncertainties considering the pathophysiology follow this condition, making 
therapeutic strategy inadequate or insufficiently good for one third of patients that enter 
chronic state of this disorder. In line with that, there are multiple causes of epilepsy which 
may have a genetic, structural or metabolic background and often the underlying cause is 
indefinite and remains to be identified. Epileptic seizures could be generalized, when 
rapidly affecting neuronal networks of both hemispheres, or they could be focal when 
affecting neuronal networks unilaterally 2.
Focal epileptic seizures frequently arise in temporal lobe, mostly in its mesial part 
comprised from amygdala, hippocampus, uncus, gyrus dentatus and parahippocampal 
gyrus. Although mesial temporal lobe epilepsy (mTLE) is one of the most common types 
of focal epilepsies, portion of the mTLE patients is difficult to treat with available 
antiepileptic drugs. Unfortunately, in time they develop drug resistant epilepsy. The most 
common cause of drug resistant mTLE is structural changes within hippocampus that 
involve different level of neuronal cell degeneration and loss (mTLE with hippocampal 
sclerosis – mTLE-HS), as well as abnormal reorganization of neuronal circuits 3.
Therefore, surgical treatment, i.e. removal of sclerotic hippocampus, was shown to be 
helpful in attaining the control over epileptic seizures in 60 – 80% of patients 4. Surgical 
failures emphasize the complexity of the condition indicating the role of other mesial 
structures in seizure development, as well as the constant need for new therapies. On the 
other side, specimens gained through these surgical interventions offer direct look into the 
“crime scene”, which could contribute to better understanding of the pathophysiological 
processes associated with mTLE-HS. There are four types of HS based on the affected 
regions and the level of neuronal loss according to International League Against Epilepsy 
(ILAE) 4.
Metals biology in epilepsy
More and more studies, point that loss of regulation of metal homeostasis in the central 
nervous system contributes to pathophysiological processes in various neurodegenerative 
diseases. For example: it is hypothesized that iron loading and beta-amyloid plaque 
pathology are synergistic events in Alzheimer’s disease (AD) 5,6; perturbations in iron and 
copper metabolism contribute to the pathology of Parkinson’s disease (PD) 7,8; mutations 
in copper-transporter protein ATP7A in Menkes disease result in severe 
neurodevelopmental deficiencies and epileptic seizures as a result of copper deficiency in 
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the brain 9; extensive research on zinc signaling in epileptic seizures indicate that interplay 
between intracellular and extracellular concentrations of this metal may contribute to 
harmful or protective effects 10. Therefore, targeting the key players of metal homeostasis 
could be helpful in treatment of neurodegenerative diseases. However, it is very 
demanding to identify precise targets responsible in maintaining balance of essential 
metals in healthy or diseased brain due to complexity of interactions among the metals 
themselves and the plethora of metalloproteins. Nevertheless, field of metal biology is 
gaining its place under the spotlight of neurosciences.
Perturbations in metal homeostasis are possible cofactor in the onset and/or progress of 
epilepsy. Meta-analysis performed by Saghazadeh and co-workers indicate differences in 
concentrations of trace elements in sera of the epilepsy patients (on or without therapy), 
and control subjects 11. However, what happens in relation of various metals 
concentrations in the brain itself exposed to epileptic seizures, remained to be determined 
and systematically analyzed. Therefore, the goal of our investigations is to contribute to 
the field of metal biology in epilepsy by determining total concentrations and regional 
distribution of some essential trace elements in sclerotic hippocampus resected from drug 
resistant mTLE-HS patents as surgical therapeutic approach. We have used two powerful 
techniques: inductively coupled plasma optical emission spectrometry (ICP-OES), to 
measure total concentrations of metals; and laser ablation inductively coupled plasma mass 
spectrometry (LA-ICP-MS) imaging, in order to provide detailed metal maps of epilepsy 
related sclerotic hippocampus. In our research we have investigated HS ILAE type 1 (HS1) 
and type 2 (HS2). HS1 is the most common among all mTLE patients that undergo 
surgical intervention, and represent severe lost of neurons in all segments of cornu amonis 
(CA1 – CA4), as well as in gyrus dentatus (GD). HS2 is the rare type seen in 5-10% of 
surgical cases of mTLE and affects exclusively CA1 region. Our strategy was to: compare 
epilepsy-induced HS with control tissue; compare regions with neuronal degeneration with 
preserved ones. 
Measurements of total concentrations of metals gained by ICP-OES can be observed in 
table 1 (adapted from 12). The profile of sodium, potassium, copper, and manganese in 
hippocampi of patients with mTLE-HS differed considerably from the control tissue. 
Disturbances in levels of main extracellular and intracellular electrolyte, i.e. increased 
sodium and lowered potassium concentration point out to the neuronal cell loss and 
changed ratio between intracellular and extracellular volume of sclerotic hippocampus. 
Further, hippocampus of mTLE patients is marked by significant copper and manganese 
deficiency 12. Spatial distribution of copper and manganese in hippocampi of patients with 
mTLE-HS acquired by LA-ICP-MS shown in figure 1, revealed that these metals mostly 
concentrate in areas reach in neuronal somata, which are the following regions of 
hippocampus: subiculum (SUB), CA4, GD, and stratum pyramidale (SPy) in CA1 and 
CA2; while alveus and other regions with axons and dendrites generally showed lower 
levels of Cu, and Mn 13. What is important is that Cu concentrations were significantly 
lower in areas of hippocampus affected with neuronal loss (SPy of CA1) compared to 
preserved regions (SUB). Furthermore, Cu and Mn concentrations positively correlated 
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with neuron somata density in the SPy of CA1 13. This is in good agreement with Cu/Mn 
deficiency registered in sclerotic hippocampi compared to controls 12.
Table 1. Hippocampal metals and electrolytes in patients with mTLE-HS and controls (data from 12).
What is the meaning of altered copper levels in hippocampus of mTLE patients? Copper 
deficiency in epilepsy-related sclerotic hippocampus may result in multiple functional 
impairment of this structure. Namely, copper is known to be modulator of synaptic 
activity, since it is released in synaptic cleft after neuronal depolarization 14. Copper is 
considered to act as negative regulator of N-methyl-D-aspartate (NMDA) receptor, which 
play important role in hippocampal neuronal excitability and impairment in Cu-
homeostasis has been associated with epileptic seizures in Menkes disease 15,16.
Furthermore, proper functioning of some important metalloprotins, such as Cu-Zn 
superoxide dismutase (CuZnSOD), dopamine >-hydroxylase, cytochrome c oxidase etc., 
critically rely on copper. However, our study on hippocampal antioxidative system in 
mTLE showed that the activity/level of CuZnSOD were not significantly different from 
those in the control hippocampi, implying that that changes in cytosolic production of 
superoxide are not implicated in generation of oxidative stress 17. On the other hand, it 
seems that reduced availability of copper affects neither levels nor activity of CuZnSOD 
12,17. Similar situation was observed in substantia nigra (SN) of PD patients, i.e. SN is the 
area defined with high neuronal loss, prominent reduction in total copper level, and the 
activity/level of CuZnSOD comparable to control 7. However, other areas of the brain of 
PD patients characterized with limited cell loss, had normal Cu level, but then increased 
activity of CuZnSOD 7. Therefore, it will be useful to determine and compare total Cu 
concentrations and activity/level of CuZnSOD in two subgroups of mTLE patients, the one 
with high degree of hippocampal sclerosis (HS1) and the other with low degree (HS2), and 
to estimate how better structural preservation influences Cu levels and functioning of 
metalloenzyme CuZnSOD. In addition, since role of copper-transporting ATPase was 
shown to be required for hippocampal neuronal activation, we hypothesize that there is 
Achilles' heel of copper turnover in mTLE-HS that causes copper deficiency and in thus 
way contribute to pathology of epileptic seizures.
Hippocampi
Metals
1μg/g of tissue
Controls (n = 17) HS (n = 24)
Na 1040 ± 25, p = 0.010 1131 ± 22
K 2322 ± 6, p < 0.001 2001 ± 59
Ca 104.6 ± 14.1, n.s. 101.0 ± 14.6
Mg 118.2 ± 4.4, n.s. 106.8 ± 3.5
Zn 10.97 ± 1.03,  n.s. 13.97 ± 1.51
Fe 61.9 ± 10.7, n.s. 62.2 ± 5.1
Cu 3.57 ± 0.33, p < 0.001 2.34 ± 0.12
Mn 0.41 ± 0.06, p = 0.004 0.205 ± 0.030
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Figure 1. Micrograph of the coronal cresyl violet stained section of a sclerotic hippocampus HS1 
and HS2, with delineated anatomical regions. LA-ICP-MS images of the subsequent coronal section 
of the same patient, presenting zinc, iron, copper, and manganese maps. GD, gyrus dentatus 
(demarcated together with the stratum moleculare, stratum granulosum and polymorphic layer); 
SUB, subiculum; SPy, stratum pyramidale; SR, stratum radiatum; SLM, strata lacunosum and 
moleculare. Straight lines demarcate different fields of the cornu ammonis (CA1–CA3). 
Manganese deficiency registered in human HS could contribute to the pathology of mTLE 
by affecting: main manganese metalloprotein and astrocytic enzyme - glutamine synthetase 
(GS); and/or member of mitochondrial antioxidative system - manganese superoxide 
dismutase (MnSOD). Indeed, down-regulation of GS has been reported previously in 
animal model of epilepsy, as well as in the hippocampus of mTLE patients 18-21. Resent 
study reported the almost exclusive astrocytic GS expression in the neuronal somatic 
layers of hippocampus of mTLE patients and that GS down-regulation positively 
correlated with the degree of neuronal loss 21. This is in line with our data that Mn 
concentrations correlated positively with neuron density in the neuronal somatic layer of 
CA1, region highly affected with neuronal loss 13. Since it was shown that manganese 
deficiency in the brain is accompanied with seizures in animal model of epilepsy, we
hypothesize that reduced concentration of manganese in human epilepsy-related HS could 
interfere with GS level/activity, which would result in augmented levels of glutamate 
leading to neuronal hyper-excitability and excitotoxicity 22. Furthermore, our data show 
that neurons with on-going degeneration were immunopositive for MnSOD 17. These 
degenerated neurons  were present in all neuronal layers, and could not be detected in areas 
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of total neuronal loss, and in regions with no neuron somata, such as alveus, which is again
in good agreement with Mn spatial organization that positively correlates with density of  
neuronal bodies 13,17.
Our results show that iron accumulation is not characteristic of sclerotic hippocampus of 
mTLE patients 12,13. Comparable iron concentrations of mTLE and control hippocampi 
support this statement. However, metal maps showed that iron mainly follows the paths of 
hippocampal blood vessels. It was hard to draw any conclusions regarding local iron 
accumulation and/or deficiency, since high amounts of this metal was resent in the
vasculature. Although, the phenomenon of hippocampal iron accumulation is the feature 
associated with other neurodegenerative diseases, such as AD and PD, it is accepted that 
epilepsy- and neurodegeneration-related pathological changes of hippocampus are 
markedly different mostly due to preserved neurogenic capacity of epileptogenic 
hippocampus 3,23.
Considering the role of metals in epilepsy, zinc signalling is the most extensively 
investigated. However, owing to the complex relationship between generation of seizures 
and zinc signalling, the data about the role of intracellular/extracellular zinc are often 
conflicting 10. Therefore, information considering total concentration, as well as providing 
data about regional distribution of this metal would help to resolve in which direction zinc 
will act. Our results show that the total level of zinc in human hippocampi obtained from 
patients with drug resistant epilepsy does not differ significantly from the levels of zinc in 
control hippocampi 12. Analysis of zinc regional distribution revealed that Zn is mainly 
located in mossy fiber reach regions: GD, CA4, and CA3. Rank of order in zinc levels in 
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validating previous findings on Zn hippocampal distribution, gained with histochemical 
staining, our results also imply that we need to go beyond regional distribution, and to map 
Zn at cellular resolution, using synchrotron-based x-ray fluorescence microscopy for 
example. That way may provide information on fine tuning of Zn levels inside and outside 
of the cell, which may give the deeper insights at the role of Zn signalling in mTLE 24-27.
Conclusion
Determining the total concentrations, as well as spatial distribution of essential metals in 
crime scene of mTLE, which is sclerotic hippocampus, contribute to overall knowledge 
about pathology of epilepsy and point to the much needed non-invasive therapeutic 
directions. Among the examined metals, we confirmed the deficiency of copper in sclerotic 
hippocampus on two levels: (i) in whole structure (ii) and locally in the areas of neuronal 
loss, with significant correlation between copper concentration and neuron density.
Therefore, our findings identify members of copper turnover, including proteins that serve 
as copper transporters, carriers and chaperons, as crucial targets of future investigation. 
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